OQS
EOLS icon

Occudo Quantitative Strategies’s Evolus EOLS Stock Holding History

Occudo Quantitative Strategies’s Portfolio EOLS Stock Details EOLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-47,502
Closed -$437K – 720
2025
Q2 		$437K Buy
+47,502
New +$486K 0.05% 375
2024
Q2 		– Sell
-34,097
Closed -$477K – 817
2024
Q1 		$477K Buy
34,097
+21,901
+180% +$285K 0.08% 317
2023
Q4 		$128K Buy
+12,196
New +$109K 0.02% 691
2023
Q3 		– Sell
-25,369
Closed -$184K – 1064
2023
Q2 		$184K Buy
25,369
+14,438
+132% +$125K 0.02% 864
2023
Q1 		$92.5K Sell
10,931
-24,643
-69% -$223K 0.01% 824
2022
Q4 		$267K Sell
35,574
-11,405
-24% -$88.3K 0.03% 699
2022
Q3 		$378K Buy
+46,979
New +$498K 0.03% 766

Other funds holding EOLS

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return

Occudo Quantitative Strategies's EOLS Position: Q3 2025 in Review

Occudo Quantitative Strategies sold out of Evolus (EOLS) in Q3 2025, closing a stake of 47,502 shares — an estimated $437K sold.

Occudo Quantitative Strategies first reported a position in EOLS in Q3 2022 and held it in 7 quarters. The position peaked at $477K in Q1 2024. 160 funds tracked by Wall St. Rank hold EOLS as of Q3 2025.

  • Occudo Quantitative Strategies reported no remaining Evolus position as of Q3 2025 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 47,502 Evolus shares in Q3 2025, an estimated $437K.
  • Occudo Quantitative Strategies first reported a position in Evolus in Q3 2022 and held it in 7 quarters.
  • Occudo Quantitative Strategies's Evolus position peaked at $477K in Q1 2024.
  • 160 funds tracked by Wall St. Rank held Evolus as of Q3 2025.

Based on Occudo Quantitative Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.